Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment

Neurology
Marcelo E BigalRichard B Lipton

Abstract

To evaluate the disability profile and patterns of treatment and health care use for chronic migraine (CM) in the general population, in contrast to episodic migraine. We identified 24,000 headache sufferers, drawn from more than 165,000 individuals representative of the US population. This sample has been followed up with annual surveys using validated questionnaires for the diagnosis of episodic migraine and CM. As a part of the survey, subjects were asked to report the specific medications currently used for their most severe headaches, as well as level of satisfaction with treatment. Our sample consisted of 520 individuals with CM and 9,424 with episodic migraine. Over a 3-month period, more than half of the individuals with CM missed at least 5 days of household work, compared with 24.3% of those with episodic migraine (p < 0.001). Reduced productivity in household work for at least 5 days over 3 months was reported by 58.1% and 18.2% (p < 0.001); at least 5 days of missed family activities was reported by 36.9% and 9.5% (p < 0.001). The majority of the CM sufferers (87.6%) had previously sought care to discuss their headaches with a health professional. Migraine-specific acute treatments were used by 31.6% of respondents ...Continue Reading

Citations

May 6, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·D D'AmicoG Bussone
May 6, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Domenico D'AmicoG Bussone
Jun 1, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·G GianniniS Cevoli
May 25, 2013·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Randall E Weeks
May 25, 2013·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Bruno ColomboGiancarlo Comi
Nov 11, 2010·Current Pain and Headache Reports·Aubrey N ManackRichard B Lipton
Nov 17, 2010·Current Pain and Headache Reports·Hans-Christoph DienerDavid Dodick
Nov 16, 2011·Current Pain and Headache Reports·Zaza KatsaravaRichard B Lipton
Apr 11, 2012·Current Pain and Headache Reports·Dawn C BuseRichard B Lipton
Dec 20, 2012·Current Pain and Headache Reports·Wei-Ta ChenShuu-Jiun Wang
Nov 17, 2010·Current Treatment Options in Neurology·Robert A NicholsonRichard B Lipton
Feb 15, 2012·Nature Reviews. Neurology·Hans-Christoph DienerStephen D Silberstein
Jul 21, 2009·Cephalalgia : an International Journal of Headache·J L NatoliR B Lipton
Sep 8, 2009·Cephalalgia : an International Journal of Headache·S J NahasS D Silberstein
Sep 8, 2010·Cephalalgia : an International Journal of Headache·Min YangMark Kosinski
Aug 3, 2011·BMC Neurology·Pablo IrimiaEduardo Martinez-Vila
Nov 3, 2012·Drugs·Ryan J CadyRoger K Cady
Jan 30, 2014·Current Pain and Headache Reports·William B Young
Oct 2, 2012·Annals of Indian Academy of Neurology·Fayyaz AhmedModar Khalil
Apr 5, 2014·Journal of Medical Internet Research·Thiago D NascimentoAlexandre F DaSilva
May 29, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·A RaggiD D'Amico
May 2, 2012·Current Opinion in Neurology·Christina I DeligianniDimos D Mitsikostas
Sep 8, 2010·Expert Review of Neurotherapeutics·Kenneth J Mack
Feb 15, 2016·Current Pain and Headache Reports·Aynur Özge, Osman Özgür Yalin
Aug 7, 2012·Expert Opinion on Emerging Drugs·Luana LionettoPaolo Martelletti
Feb 11, 2016·Neuromodulation : Journal of the International Neuromodulation Society·Shannon W ClarkAshwini D Sharan
Feb 21, 2016·Clinical Neurology and Neurosurgery·Soma Sahai-SrivastavaLilyana Amezcua
Nov 26, 2013·Journal of the Chinese Medical Association : JCMA·Kuan-Hsiang LinShuu-Jiun Wang
Nov 23, 2013·Neurosurgery Clinics of North America·Daryoush Tavanaiepour, Robert M Levy
Feb 24, 2016·Current Neurology and Neuroscience Reports·Anna Gryglas
Apr 23, 2013·Revue neurologique·D Valade
Dec 24, 2015·Current Pain and Headache Reports·Soo-Jin ChoMin Kyung Chu
Jan 6, 2016·Current Pain and Headache Reports·Christina Sun-Edelstein, Alan M Rapoport
Mar 1, 2016·Current Treatment Options in Neurology·Oved Daniel, Alexander Mauskop
Mar 2, 2010·Drug and Alcohol Dependence·Wendy M WalwynChristopher J Evans
Dec 1, 2011·The Journal of Headache and Pain·Jun WuPeggy J Wagner
Apr 25, 2012·The Journal of Headache and Pain·Yong-Chen ChenShuu-Jiun Wang
Sep 26, 2012·The Journal of Headache and Pain·Sait AshinaDawn C Buse
Oct 17, 2012·The Journal of Headache and Pain·Tzu-Hsien LaiShuu-Jiun Wang
Nov 28, 2015·Journal of Behavioral Medicine·Michael J McDermottMatthew T Tull

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.